NCT05109442
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05109442
Title Study to Assess AFM24 in Combination with Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Affimed GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | GBR | ESP

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Independent Public Teaching Hospital #4 in Lublin, Department of Clinical Oncology and Chemotherapy Lublin 20-954 Poland Details
European Health Center Otwock Fryderyk Chopin Hospital, Department of Clinical Oncology Otwock 05-400 Poland Details
MED-Polonia, Sp. z o.o. (LLC) Poznan 60-693 Poland Details
Janusz Korczak Provincial Specialist Hospital in Slupsk Limited Liability Company Słupsk 76-200 Poland Details
Maria Sklodowska-Curie - National Research Institute of Oncology, Early Phase Research Department Warsaw 02-781 Poland Details
Seoul National University Bundang Hospital Seongnam-si 13620 South Korea Details
Severance Hospital, Yonsei University Health System Seoul 03722 South Korea Details
The Catholic University of Korea St. Vincent's Hospital Suwon 93 South Korea Details
Vall d'Hebron Institute of Oncology (VHIO) Barcelona 08035 Spain Details
University Hospital Quiron Madrid Madrid 28223 Spain Details
University Clinic of Navarra - Pamplona Pamplona 31008 Spain Details
Hospital Clinic Universitario Biomedical Research institute INCLIVA Valencia 46010 Spain Details
Royal Marsden NHS Foundation Trust - ICR Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field